Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia
Cystic fibrosis is a genetic disorder of the exocrine glands, and affects the pancreas, respiratory system, and sweat glands. It is characterized by chronic respiratory infection, impaired function of the pancreas, and increased levels of electrolytes in sweat. Patients with cystic fibrosis have an increased risk of developing infection with Pseudomonas cepacia, a bacteria shown to be resistant to several antimicrobial agents. In patients with cystic fibrosis, persistent infection of the lungs with P. cepacia is associated with increased disability and decreased survival. The patterns of infection, which may be either continuous or recurrent, and numbers of bacterial strains involved in P. cepacia infection have not been clarified in this population. Ribotype analysis is a genetic method for distinguishing bacterial strains, and was shown to be effective in differentiating strains of P. cepacia. Ribotyping was used to identify strains of P. cepacia obtained from 12 cystic fibrosis patients with chronic respiratory infection due to P. cepacia. A single strain of P. cepacia caused chronic respiratory infection in 9 of 12 patients, whereas a total 2 genetically different strains of P. cepacia were found in the 3 remaining patients. A change in the infecting strain in two patients was not associated with a change in either patient's clinical condition. The findings show that chronic P. cepacia infection of the lung in cystic fibrosis patients is most frequently caused by a single strain of this bacteria. (Consumer Summary produced by Reliance Medical Information, Inc.)
Publication Name: Journal of Infectious Diseases
Purpuric rashes in cystic fibrosis
Cystic fibrosis is a genetic disorder of the glands that secrete through ducts, the exocrine glands, such as mucus glands, sweat glands and the pancreas. A few patients with cystic fibrosis have reported rashes, either with or without associated arthritis (joint swelling). Purpura, pinpoint bleeding below the skin's surface, can occur in conjunction with itching and burning primarily on the legs and feet. Of the 500 patients with cystic fibrosis that were studied, sixteen were found to have rashes. The condition can be brought about by standing for a long time. It is similar to hypergammaglobulinemia purpura, a condition caused by an increase in gammaglobulin G, an antibody produced by the body. Although all patients were taking antibiotics for lung infections and there was no observable relationship between the rash and any specific drugs, drug hypersensitivity cannot be excluded. Perhaps a hypersensitive reaction to bacteria caused tissue damage and swelling. Cystic fibrosis patients with hypergammaglobulinemia have more lung problems, are more ill and have poorer survival than patients with normal gammaglobulin G levels. Purpuric rashes are probably secondary to the severe lung complications found in very ill patients with cystic fibrosis. (Consumer Summary produced by Reliance Medical Information, Inc.)
Publication Name: American Journal of Diseases of Children
Cystic fibrosis - a full-time occupation or more a way of life?
Cystic fibrosis is among the most common inherited genetic disorder in the United States afflicting one in every 20 individuals. Regular chest physiotherapy is vitally important to the CF patient and at the time of CF diagnosis, each patient should be assessed and a treatment programme initiated based on the individual needs of the family. It is very important that health workers closely monitor the patient and support the family since a lot is expected from day-to-day living with a CF patient.
Publication Name: European Journal of Clinical Nutrition
- Abstracts: Treatment of bacterial meningitis. Assessment and treatment of suicidal patients. The treatment of malaria
- Abstracts: The quality of life after breast cancer -- solving the problem of lymphedema. A 67-year-old woman with increasing neurologic deficits and a history of breast and ovarian cancer
- Abstracts: A 57-year-old woman with a pulmonary mass. Gas embolism. Vena caval filters for the prevention of pulmonary embolism
- Abstracts: Epoprostenol for primary pulmonary hypertension. Hypertension with a grain of salt
- Abstracts: The Safety of New Medicines: The Importance of Asking the Right Questions. Making it easy to do it right